Upcoming Allied Market Research
Skeletal Dysplasia Market

Skeletal Dysplasia Market

by Type (Achondroplasia, Hypochondroplasia, Thanatophoric Dysplasia, Osteogenesis Imperfect, and Others), Treatment (Medication, Surgery, and Others), and End User (Hospitals, Clinics, and Other): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A14433
Pages: NA
Nov 2022 | 455 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Skeletal Dysplasia Market

Request Now !

Skeletal dysplasia is a rare disease that has more than 450 types. It is also known as osteochondrodysplasias. The growth and development of cartilage and bone get affected by this disease. The level of severity of the disease varies from neonatal lethality to growth difference in adulthood. Skeletal dysplasia is complex to diagnose, as it is a rare disorder. Some of the major symptoms are deformities in the large head, slow growth, curved bones, short upper arms or thighs, and joint pain or arthritis.

The disorder is highly prevalent in children and early treatment can help to create awareness. This disorder is a result of defective genes, which are either mutated during the development of the fetus or inherited from parents. The defective gene is most complex to identify. Hence, companies are making handsome investments in research & development for the treatment of this rare disease.

COVID-19 Scenario Analysis: 

  • The outbreak of COVID-19 is likely to have a moderate impact on the market in the forecast period. Research and development activities to identify the threat of the SARS-CoV-2 virus on the patients suffering are likely to slow the market growth.
  • COVID-19 has brought about a significant burden on the healthcare industry globally, with disruption in the treatment of non-communicable diseases. Challenges exist in providing effective care.
  • Realizing the disturbing healthcare trends, governments globally are making efforts to provide excellent quality healthcare to patients globally. Nationwide lockdowns, cancelled or postponed elective surgeries, denied wound care services, rise in skin injuries in COVID-19, the market is expected to show a decline during the forecast timeline. However, on the flip side, the latter half of the forecast is predicted to show a drastic rise.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Increasing awareness and early diagnosis of skeletal dysplasia are driving the global dysplasia market. As per Johns Hopkins Medicine, the conditions affect nearly 2.4% of 10,000 births, with achondroplasia, which is the most common one.
Novel drugs commercialization and the presence of pipeline products are the core factors predicted to fuel the growth of the market. For example, Denosumab is being developed by Amgen Inc., a phase III clinical trial product for treating Osteogenesis Imperfecta (OI), which is also known as brittle bone disease. Osteogenesis Imperfecta is one of the types of skeletal dysplasia which causes extremely short limbs. Similarly, Recombinant human growth hormone (r-hGH) for hypochondroplasia is been developed by Merck KGaA and is currently in clinical trials phase II. Additionally, BMN 111, currently under clinical trial phase III for treating achondroplasia in children is been developed by BioMarin.

Achondroplasia is one of the types of skeletal dysplasia that obstructs the change of cartilage to bone.

Increasing awareness of skeletal dysplasia is also predicted to boost market growth. The SKELDYS.ORG and Fetal Medicine Foundation are some of the online portals that provide information about available treatment options and diagnoses for different types of skeletal dysplasia. Additionally, emerging drug therapies for treating the disorder are witnessed to contribute to the growth of the market over the forecast timeline. Cell-based therapy with mesenchymal cell & gene therapy involving allele silencing with bone marrow transplantation is one of the most promising therapeutic options for research.

Key players are hugely investing in advanced development treatments of this condition. Also, rise in prevalence of skeletal muscle dysplasia has been increasing in children. These factors are expected to fuel the market globally. As per a journal published up to date frequency of skeletal muscle dysplasia during pregnancy is witnessed to be 7.5% in 100,000 women screened through ultrasound. Individuals with this condition undergo extensive surgical and medical treatments throughout childhood and adulthood.

North America is witnessed to dominate the market in the forecast timeline because of the factors like awareness for the treatment of orthopedic and medical conditions, high health care expenditure, and presence of core players involvement in the market. Also, awareness for early diagnosis, advanced healthcare facilities, and recognition of orphan drugs by the government is likely to boost the market of skeletal dysplasia in the U.S.

The market in Asia-Pacific is predicted to expand rapidly during the forecast timeline. Incidence of rare disorders like skeletal dysplasia, the prevalence in children, early diagnosis, are core factors that are fueling the market in the region. International & national collaboration with advancements in technology are anticipated to boost the market of skeletal dysplasia in Asia-Pacific.

Key Segments Covered:




  • Achondroplasia
  • Hypochondroplasia
  • Thanatophoric Dysplasia
  • Osteogenesis Imperfect
  • Others


  • Medication
  • Surgery
  • Others

  End User

  • Hospitals
  • Clinics
  • Other


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report:

  • This study presents the analytical depiction of the global skeletal dysplasia market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global skeletal dysplasia market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global skeletal dysplasia market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global skeletal dysplasia market analysis based on competitive intensity and how the competition will take shape in the coming years. 

Questions Answered in the Skeletal Dysplasia Market Research Report:

  • What are the leading market players active in the skeletal dysplasia market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Skeletal Dysplasia Market Report Highlights

Aspects Details
By Type
  • Achondroplasia
  • Hypochondroplasia
  • Thanatophoric Dysplasia
  • Osteogenesis Imperfect
  • Others
By Treatment
  • Medication
  • Surgery
  • Others
By End User
  • Hospitals
  • Clinics
  • Others
By Region
  • North America  (U.S, Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Amgen Inc, Merck KGaA, Regeneron, BioMarin Pharmaceutic, Clementia Pharmaceuticals, Regeneron Pharmaceuticals, Ultragenyx Pharmaceutical, Alexion Pharmaceuticals

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Skeletal Dysplasia Market

Start reading.
This Report and over 19,255+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers